(Q38035070)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897924%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Pediatric neuro-oncology: current status and future directions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897924%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897924%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

John A Heath

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897924%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Stergios Zacharoulis

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897924%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

18 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897924%20AND%20SRC:MED&resulttype=core&format=json

Asia Pacific Journal of Clinical Oncology

11 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897924%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897924%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897924%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

223-231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897924%20AND%20SRC:MED&resulttype=core&format=json

Multidisciplinary management of childhood brain tumors: a review of outcomes, recent advances, and challenges

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Childhood medulloblastoma: current status of biology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Cerebrospinal fluid M staging for medulloblastoma: reappraisal of Chang's M staging based on the CSF flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Extraneural metastases in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Clinical and pathological features of paediatric malignant rhabdoid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Appraisal of the current staging system for residual medulloblastoma by volumetric analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Risk-adapted chemotherapy in childhood medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Brain tumors across the age spectrum: biology, therapy, and late effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Childhood brain tumors: epidemiology, current management and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Reirradiation and concomitant metronomic temozolomide: an efficient combination for local control in medulloblastoma disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Treatment of early childhood medulloblastoma by postoperative chemotherapy alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

FISH and chips: the recipe for improved prognostication and outcomes for children with medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Expression of Notch and Wnt pathway components and activation of Notch signaling in medulloblastomas from heterozygous patched mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

21 January 2018

Ependymoma: an update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Treatment and outcome of children with relapsed ependymoma: a multi-institutional retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Outcomes of malignant CNS ependymomas: an examination of 2408 cases through the Surveillance, Epidemiology, and End Results (SEER) database (1973-2005).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Supratentorial ependymoma in children: to observe or to treat following gross total resection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Is craniospinal irradiation required to cure children with malignant (anaplastic) intracranial ependymomas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Genetic abnormalities detected in ependymomas by comparative genomic hybridisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

New chemotherapy strategies and biological agents in the treatment of childhood ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Immunohistochemical markers for prognosis of ependymal neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

The WHO classification of tumors of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

MGMT gene promoter methylation in pediatric glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Diffuse brainstem glioma in children: critical review of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Primary neurosurgery for pediatric low-grade gliomas: a prospective multi-institutional study from the Children's Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Long-term follow up of 69 patients treated for optic pathway tumours before the chemotherapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Phase II trial of conformal radiation therapy for pediatric low-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Brain tumors: from childhood through adolescence into adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Analysis of VEGF, Flt-1, Flk-1, nestin and MMP-9 in relation to astrocytoma pathogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Tumour control by whole brain irradiation of anti-VEGF-treated mice bearing intracerebral glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Treatment of high-grade glioma in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Evaluation of gefitinib for treatment of refractory solid tumors and central nervous system malignancies in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Nimotuzumab for pediatric diffuse intrinsic pontine gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X

Combined treatment with temozolomide and methoxyamine: blocking apurininc/pyrimidinic site repair coupled with targeting topoisomerase IIalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1743-7563.2012.01558.X